<?xml version="1.0"?>

<document>
	<title>Cystic fibrosis liver sialyltransferase.</title>

	<author>Alhadeff-J-A.</author>
	<author>Cimino-G.</author>

	<source>Clin-Genet. 1978 Feb. 13(2). P 207-12.</source>

	<abstract>The activity of sialytransferase with regard to the glycoprotein
   substrates asialofetuin and asialo-ovine submaxillary mucin was
   determined in normal, pathological control, and cystic fibrosis liver
   homogenates. Cystic fibrosis and pathological livers have about 40%
   of the average normal specific activity for sialytransferase. Several
   properties of cystic fibrosis sialytransferase were investigated and
   compared to those of the normal liver enzyme (Alhadeff et al. 1977).
   The pH optima curves were similar, but cystic fibrosis
   sialyltransferase appears to be more thermolabile than the normal
   liver enzyme. Isoelectric focusing studies revealed that the three
   most basic forms of sialyltransferase which are found in normal
   livers are deficient or absent in most cystic fibrosis liver. The
   data suggest that altered glycoprotein-sialyltransferases may be
   present in cystic fibrosis livers, probably a secondary effect due to
   general liver pathology.</abstract>

	<majorsubject>CYSTIC-FIBROSIS: en</majorsubject>
	<majorsubject>LIVER: en</majorsubject>
	<majorsubject>SIALYLTRANSFERASES: me</majorsubject>
	<majorsubject>TRANSFERASES: me</majorsubject>

	<minorsubject>HUMAN</minorsubject>
	<minorsubject>HYDROGEN-ION-CONCENTRATION</minorsubject>
	<minorsubject>ISOELECTRIC-FOCUSING</minorsubject>
	<minorsubject>LIVER-DISEASES: en</minorsubject>
	<minorsubject>TEMPERATURE</minorsubject>

	<reference>001   ALHADEFF JA           BIOCHIM BIOPHYS ACTA           484   307 977</reference>
	<reference>002   ALHADEFF JA           CLIN CHIM ACTA                  57   307 974</reference>
	<reference>003   ALHADEFF JA           DEVELOP BIOL                    47   319 975</reference>
	<reference>004   ALHADEFF JA           CLIN GENET                      10    63 976</reference>
	<reference>005   GOLDSTONE AP          FEBS LETTERS                    13    68 971</reference>
	<reference>006   KATTWINKEL J          J PEDIATR                       82   234 973</reference>
	<reference>007   LOBECK CC             IN: STANBURY JB                     1605 972</reference>
	<reference>008   LOWRY OH              J BIOL CHEM                    193   265 951</reference>
	<reference>009   MCCOMBS ML            TEX REP BIOL MED                31   615 973</reference>
	<reference>010   MOOKERJEA S           CAN J BIOCHEM                   50   738 972</reference>
	<reference>011   MURPHY WH             BIOCHIM BIOPHYS ACTA            52   349 961</reference>
	<reference>012   SCHACHTER H           IN: FISHMAN WH                   3     2 973</reference>
	<reference>013   SPIRO RG              J BIOL CHEM                    235  2860 960</reference>
	<reference>014   SPIRO RG              ADV PROT CHEM                   27   349 973</reference>
	<reference>015   TETTAMANTI G          ARCH BIOCHEM BIOPHYS           124    41 968</reference>
	<reference>016   THORPE R              FEBS LETTERS                    54    89 975</reference>
	<reference>017   WARREN L              J BIOL CHEM                    234  1971 959</reference>

	<citation>1   ALHADEFF JA           CLIN GENET                      13   417 978</citation>
	<citation>2   ALHADEFF JA           CLIN GENET                      14   189 978</citation>
	<citation>3   LAPINA EB             BIOORGAN KHIM                    5  1720 979</citation>
	<citation>4   ANFIMOVA ML           BIOORGAN KHIM                    7  1209 981</citation>
	<citation>5   HULTBERG B            CLIN CHIM ACTA                 112   167 981</citation>
	<citation>6   MARGOLIES R           PEDIATR RES                     17   931 983</citation>
	<citation>7   PASCALI VL            EUR J PEDIATR                  143   133 984</citation>

</document>
